In addition, a previous study conducted by Chien KL, et al. reported that a strong association of the SREBP-1 rs9902941 polymorphism with the reduction of LDL-C after statin treatment, and it was observed among Chinese patients with hypercholesterolemia [29]. Here, SREBF1 is linked to familial hypercholesterolemia.